Header Logo

Connection

Alan Landay to HIV Infections

Back to Details
This is a "connection" page, showing publications Alan Landay has written about HIV Infections.
Alan Landay
Connection Strength
31.463
HIV Infections
  1. Time to Study Immune Checkpoint Inhibitors in Patients With HIV Infection and Cancer. JCO Oncol Pract. 2020 06; 16(6):327-328.
    View in: PubMed
    Score: 0.438
  2. A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2020 05; 36(5):349-356.
    View in: PubMed
    Score: 0.438
  3. A Summary of the Third Annual HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2018 10; 34(10):828-834.
    View in: PubMed
    Score: 0.397
  4. HIV and aging: role of the microbiome. Curr Opin HIV AIDS. 2018 Jan; 13(1):22-27.
    View in: PubMed
    Score: 0.376
  5. A Summary of the Second Annual HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2017 12; 33(12):1258-1264.
    View in: PubMed
    Score: 0.371
  6. Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System. J Immunol. 2017 01 15; 198(2):605-614.
    View in: PubMed
    Score: 0.352
  7. A Summary of the First HIV Microbiome Workshop 2015. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):935-941.
    View in: PubMed
    Score: 0.340
  8. Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS. 2016 May; 11(3):253-60.
    View in: PubMed
    Score: 0.335
  9. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women. AIDS Res Hum Retroviruses. 2016 Feb; 32(2):134-43.
    View in: PubMed
    Score: 0.323
  10. HIV-associated mucosal gene expression: region-specific alterations. AIDS. 2015 Mar 13; 29(5):537-46.
    View in: PubMed
    Score: 0.310
  11. Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery. AIDS Res Hum Retroviruses. 2015 Feb; 31(2):208-16.
    View in: PubMed
    Score: 0.302
  12. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders. Clin Immunol. 2015 Jan; 156(1):28-35.
    View in: PubMed
    Score: 0.302
  13. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014 Oct 15; 210(8):1248-59.
    View in: PubMed
    Score: 0.292
  14. HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients. AIDS. 2014 Mar 13; 28(5):739-43.
    View in: PubMed
    Score: 0.289
  15. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 2014 Feb; 10(2):e1003829.
    View in: PubMed
    Score: 0.288
  16. The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women. Viral Immunol. 2014 Feb; 27(1):20-5.
    View in: PubMed
    Score: 0.287
  17. A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1353-60.
    View in: PubMed
    Score: 0.278
  18. GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS. 2013 Jul 17; 27(11):1829-32.
    View in: PubMed
    Score: 0.276
  19. Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS. 2013 Jun 19; 27(10):1563-71.
    View in: PubMed
    Score: 0.275
  20. HIV: so near and yet so far. Curr HIV/AIDS Rep. 2013 Mar; 10(1):1-2.
    View in: PubMed
    Score: 0.269
  21. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8? T cell function in vitro. J Leukoc Biol. 2013 May; 93(5):811-8.
    View in: PubMed
    Score: 0.269
  22. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS One. 2012; 7(11):e50563.
    View in: PubMed
    Score: 0.264
  23. Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary. AIDS Res Hum Retroviruses. 2012 Nov; 28(11):1389-96.
    View in: PubMed
    Score: 0.262
  24. Effector and regulatory roles for B cells in HIV infection? Autoimmunity. 2012 Aug; 45(5):348-52.
    View in: PubMed
    Score: 0.258
  25. Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS. 2010 Nov; 5(6):498-503.
    View in: PubMed
    Score: 0.229
  26. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis. 2010 Jun 15; 201(12):1796-805.
    View in: PubMed
    Score: 0.223
  27. Elevated caspase-3 expression and T-cell activation in elite suppressors. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):110-1.
    View in: PubMed
    Score: 0.221
  28. Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010 Feb; 7(1):4-10.
    View in: PubMed
    Score: 0.217
  29. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis. 2009 Oct 15; 200(8):1212-5.
    View in: PubMed
    Score: 0.213
  30. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol. 2009 Mar; 130(3):298-303.
    View in: PubMed
    Score: 0.200
  31. The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J Acquir Immune Defic Syndr. 2008 Aug 15; 48(5):577-80.
    View in: PubMed
    Score: 0.196
  32. Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women. AIDS Res Hum Retroviruses. 2008 Jul; 24(7):973-6.
    View in: PubMed
    Score: 0.195
  33. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis. 2008 May 15; 197(10):1402-7.
    View in: PubMed
    Score: 0.193
  34. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS. 2008 Mar 30; 22(6):671-83.
    View in: PubMed
    Score: 0.191
  35. Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol. 2007 Nov-Dec; 250(1-2):75-84.
    View in: PubMed
    Score: 0.190
  36. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008 Apr; 127(1):1-6.
    View in: PubMed
    Score: 0.190
  37. Immunophenotypic alterations in acute and early HIV infection. Clin Immunol. 2007 Dec; 125(3):299-308.
    View in: PubMed
    Score: 0.185
  38. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol. 2007 Sep; 14(9):1102-7.
    View in: PubMed
    Score: 0.183
  39. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology. 2007 Apr; 120(4):526-35.
    View in: PubMed
    Score: 0.178
  40. Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. Clin Infect Dis. 2007 Mar 01; 44(5):749-54.
    View in: PubMed
    Score: 0.176
  41. Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy. Expert Rev Anti Infect Ther. 2006 Oct; 4(5):767-80.
    View in: PubMed
    Score: 0.172
  42. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol. 2005 May; 12(5):622-31.
    View in: PubMed
    Score: 0.156
  43. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals. FEMS Immunol Med Microbiol. 2005 Aug 01; 45(2):129-36.
    View in: PubMed
    Score: 0.155
  44. Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response. J Infect Dis. 2004 May 15; 189(10):1811-20.
    View in: PubMed
    Score: 0.146
  45. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Med. 2004 Jan; 5(1):55-65.
    View in: PubMed
    Score: 0.142
  46. Evaluating the Sick Quitting Hypothesis for Frailty Status and Reducing Alcohol Use Among People With HIV in a Longitudinal Clinical Cohort Study. J Assoc Nurses AIDS Care. 2024 Jan-Feb 01; 35(1):5-16.
    View in: PubMed
    Score: 0.142
  47. Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen. J Infect Dis. 2003 Nov 15; 188(10):1444-54.
    View in: PubMed
    Score: 0.141
  48. Tobacco Smoking and Pack-Years Are Associated With Frailty Among People With HIV. J Acquir Immune Defic Syndr. 2023 10 01; 94(2):135-142.
    View in: PubMed
    Score: 0.140
  49. Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection. Clin Infect Dis. 2023 07 26; 77(2):272-279.
    View in: PubMed
    Score: 0.138
  50. Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs. J Infect Dis. 2003 Jul 15; 188(2):209-18.
    View in: PubMed
    Score: 0.138
  51. Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection. Microbiome. 2023 05 27; 11(1):119.
    View in: PubMed
    Score: 0.137
  52. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. Front Immunol. 2023; 14:1146704.
    View in: PubMed
    Score: 0.137
  53. HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's Interagency HIV study. PLoS One. 2023; 18(5):e0285926.
    View in: PubMed
    Score: 0.136
  54. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection. AIDS. 2024 Feb 01; 38(2):223-233.
    View in: PubMed
    Score: 0.136
  55. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 2003 Mar 07; 17(4):455-80.
    View in: PubMed
    Score: 0.135
  56. Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIV. AIDS. 2023 05 01; 37(6):967-975.
    View in: PubMed
    Score: 0.134
  57. HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway. Curr Opin HIV AIDS. 2023 03 01; 18(2):102-110.
    View in: PubMed
    Score: 0.133
  58. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel. Lancet HIV. 2022 11; 9(11):e791-e800.
    View in: PubMed
    Score: 0.131
  59. Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatment. Drug Alcohol Depend. 2022 11 01; 240:109649.
    View in: PubMed
    Score: 0.131
  60. Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells. BMC Biol. 2022 09 01; 20(1):193.
    View in: PubMed
    Score: 0.130
  61. Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging. Clin Infect Dis. 2022 08 24; 75(1):73-80.
    View in: PubMed
    Score: 0.130
  62. CCR5 and CXCR4 expression after highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr. 2002 Aug 01; 30(4):458-60.
    View in: PubMed
    Score: 0.129
  63. Elevated CD4 + T-cell glucose metabolism in HIV+ women with diabetes mellitus. AIDS. 2022 08 01; 36(10):1327-1336.
    View in: PubMed
    Score: 0.128
  64. Obesity in HIV infection: host-pathogen interaction. AIDS. 2022 09 01; 36(11):1477-1491.
    View in: PubMed
    Score: 0.128
  65. Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection. Arterioscler Thromb Vasc Biol. 2022 08; 42(8):1081-1093.
    View in: PubMed
    Score: 0.128
  66. Antigen-presenting cells in HIV pathogenesis and therapy: summary of the October 17-18, 2002, Think Tank meeting. Clin Immunol. 2002 Jun; 103(3 Pt 1):243-8.
    View in: PubMed
    Score: 0.128
  67. Editorial: Advances in T Cell Therapeutic Vaccines for HIV. Front Immunol. 2022; 13:905836.
    View in: PubMed
    Score: 0.127
  68. Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV. AIDS. 2022 03 15; 36(4):501-511.
    View in: PubMed
    Score: 0.126
  69. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Clin Infect Dis. 2022 03 09; 74(5):865-870.
    View in: PubMed
    Score: 0.126
  70. T-Cell Immune Dysregulation and Mortality in Women With Human Immunodeficiency Virus. J Infect Dis. 2022 02 15; 225(4):675-685.
    View in: PubMed
    Score: 0.125
  71. HIV and Aging in the Era of ART and COVID-19: Symposium Overview. J Acquir Immune Defic Syndr. 2022 02 01; 89(Suppl 1):S3-S9.
    View in: PubMed
    Score: 0.125
  72. Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach. J Acquir Immune Defic Syndr. 2022 02 01; 89(Suppl 1):S34-S46.
    View in: PubMed
    Score: 0.125
  73. A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment. AIDS Res Hum Retroviruses. 2022 03; 38(3):173-180.
    View in: PubMed
    Score: 0.125
  74. Menopause Is Associated With Immune Activation in Women With HIV. J Infect Dis. 2022 01 18; 225(2):295-305.
    View in: PubMed
    Score: 0.124
  75. Trophoblasts are productively infected by CD4-independent isolate of HIV type 1. AIDS Res Hum Retroviruses. 2002 Jan 01; 18(1):13-7.
    View in: PubMed
    Score: 0.124
  76. HIV immunology better understood and vaccination attempts started. AIDS. 2002; 16 Suppl 4:S85-8.
    View in: PubMed
    Score: 0.124
  77. Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy. AIDS. 2021 12 01; 35(15):2489-2495.
    View in: PubMed
    Score: 0.123
  78. Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A. AIDS. 2021 10 01; 35(12):1881-1894.
    View in: PubMed
    Score: 0.122
  79. Brief Report: Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV. J Acquir Immune Defic Syndr. 2021 10 01; 88(2):186-191.
    View in: PubMed
    Score: 0.122
  80. Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS. 2001 Sep 07; 15(13):1635-41.
    View in: PubMed
    Score: 0.121
  81. Plasma Citrate and Succinate Are Associated With Neurocognitive Impairment in Older People With HIV. Clin Infect Dis. 2021 08 02; 73(3):e765-e772.
    View in: PubMed
    Score: 0.121
  82. The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection. Front Immunol. 2021; 12:695674.
    View in: PubMed
    Score: 0.120
  83. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021 06 29; 12(1):3922.
    View in: PubMed
    Score: 0.120
  84. HIV in the female genital tract: viral shedding and mucosal immunity. Clin Obstet Gynecol. 2001 Jun; 44(2):144-53.
    View in: PubMed
    Score: 0.119
  85. Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction. Front Immunol. 2021; 12:673061.
    View in: PubMed
    Score: 0.119
  86. Effects of cocaine and HIV on decision-making abilities. J Neurovirol. 2021 06; 27(3):422-433.
    View in: PubMed
    Score: 0.119
  87. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis. Front Immunol. 2021; 12:664371.
    View in: PubMed
    Score: 0.118
  88. Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV. Cardiovasc Res. 2021 03 21; 117(4):1166-1177.
    View in: PubMed
    Score: 0.117
  89. Association of Monocyte Migration Marker CD11b With Pulmonary Function in People Living With HIV. J Acquir Immune Defic Syndr. 2021 03 01; 86(3):344-352.
    View in: PubMed
    Score: 0.117
  90. Food Insecurity and T-cell Dysregulation in Women Living With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2021 03 01; 72(5):e112-e119.
    View in: PubMed
    Score: 0.117
  91. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. mBio. 2021 02 23; 12(1).
    View in: PubMed
    Score: 0.117
  92. Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV. J Acquir Immune Defic Syndr. 2021 02 01; 86(2):208-212.
    View in: PubMed
    Score: 0.116
  93. Vaccines and immunology. Recent advances in HIV/AIDS vaccine development. AIDS. 2001; 15 Suppl 5:S101-3.
    View in: PubMed
    Score: 0.116
  94. Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus. Clin Infect Dis. 2020 12 03; 71(9):2345-2353.
    View in: PubMed
    Score: 0.115
  95. Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy. J Infect Dis. 2020 11 09; 222(11):1837-1842.
    View in: PubMed
    Score: 0.115
  96. A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2020 11; 36(11):886-895.
    View in: PubMed
    Score: 0.113
  97. A look at HIV immune research. Interview by Alan Huff. Res Initiat Treat Action. 2000 Sep; 6(3):30-3.
    View in: PubMed
    Score: 0.113
  98. T Lymphocyte Subsets Associated With Prevalent Diabetes in Veterans With and Without Human Immunodeficiency Virus. J Infect Dis. 2020 06 29; 222(2):252-262.
    View in: PubMed
    Score: 0.112
  99. Sleep Health Should be Included as a Therapeutic Target in the Treatment of HIV. AIDS Res Hum Retroviruses. 2020 08; 36(8):631.
    View in: PubMed
    Score: 0.111
  100. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS. 2000 May 05; 14(7):761-70.
    View in: PubMed
    Score: 0.111
  101. Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers. Clin Infect Dis. 2020 04 10; 70(8):1636-1642.
    View in: PubMed
    Score: 0.110
  102. Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases. Curr HIV/AIDS Rep. 2020 04; 17(2):125-137.
    View in: PubMed
    Score: 0.110
  103. Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020 09; 13(5):753-766.
    View in: PubMed
    Score: 0.109
  104. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis. 2000 Jan; 181(1):358-63.
    View in: PubMed
    Score: 0.108
  105. Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs. J Acquir Immune Defic Syndr. 2019 12 15; 82(5):503-513.
    View in: PubMed
    Score: 0.108
  106. Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy. AIDS. 2019 12 01; 33(15):2289-2298.
    View in: PubMed
    Score: 0.107
  107. A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clin Infect Dis. 2019 09 13; 69(7):1165-1172.
    View in: PubMed
    Score: 0.106
  108. Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression. Clin Infect Dis. 2019 08 01; 69(4):676-686.
    View in: PubMed
    Score: 0.105
  109. Loss of CXCR4 on non-classical monocytes in participants of the Women's Interagency HIV Study (WIHS) with subclinical atherosclerosis. Cardiovasc Res. 2019 05 01; 115(6):1029-1040.
    View in: PubMed
    Score: 0.103
  110. Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women. J Acquir Immune Defic Syndr. 2019 05 01; 81(1):36-43.
    View in: PubMed
    Score: 0.103
  111. CD8+ lymphocytes in pregnancy and HIV infection: characterization of CD8+ subpopulations and CD8+ noncytotoxic antiviral activity. AIDS Res Hum Retroviruses. 1999 May 01; 15(7):665-70.
    View in: PubMed
    Score: 0.103
  112. Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection. Circulation. 2019 04 23; 139(17):2003-2011.
    View in: PubMed
    Score: 0.103
  113. Small differences in CD4+ T-cell production may go unnoticed. AIDS. 1999 Feb 04; 13(2):290-1.
    View in: PubMed
    Score: 0.101
  114. Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation. Lancet. 1999 Jan 16; 353(9148):211-2.
    View in: PubMed
    Score: 0.101
  115. Food Insecurity Is Associated With Inflammation Among Women Living With HIV. J Infect Dis. 2019 01 09; 219(3):429-436.
    View in: PubMed
    Score: 0.101
  116. Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection. EBioMedicine. 2018 Nov; 37:392-400.
    View in: PubMed
    Score: 0.099
  117. Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection. J Infect Dis. 2018 09 22; 218(9):1474-1479.
    View in: PubMed
    Score: 0.099
  118. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 08 16; 67(5):770-777.
    View in: PubMed
    Score: 0.098
  119. A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS. 2018 07 31; 32(12):1599-1611.
    View in: PubMed
    Score: 0.098
  120. Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis. Clin Infect Dis. 2018 07 02; 67(2):235-242.
    View in: PubMed
    Score: 0.097
  121. Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy. J Infect Dis. 2018 06 20; 218(2):239-248.
    View in: PubMed
    Score: 0.097
  122. Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals. Front Immunol. 2018; 9:900.
    View in: PubMed
    Score: 0.096
  123. Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. J Leukoc Biol. 2018 09; 104(3):461-471.
    View in: PubMed
    Score: 0.096
  124. Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era? J Infect Dis. 2018 01 30; 217(4):521-528.
    View in: PubMed
    Score: 0.095
  125. Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection. Clin Immunol Immunopathol. 1997 Dec; 85(3):273-81.
    View in: PubMed
    Score: 0.093
  126. Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):431-437.
    View in: PubMed
    Score: 0.093
  127. Immune restoration following treatment. Abstract and Commentary. JAMA. 1997 Nov 12; 278(18):1538.
    View in: PubMed
    Score: 0.093
  128. The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis. Viruses. 2017 10 19; 9(10).
    View in: PubMed
    Score: 0.093
  129. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 10 17; 216(7):813-818.
    View in: PubMed
    Score: 0.093
  130. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals. AIDS. 2017 09 24; 31(15):2059-2067.
    View in: PubMed
    Score: 0.092
  131. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26.
    View in: PubMed
    Score: 0.092
  132. Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):e132-e141.
    View in: PubMed
    Score: 0.092
  133. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunol. 2018 03; 11(2):449-461.
    View in: PubMed
    Score: 0.091
  134. Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy. PLoS One. 2017; 12(7):e0180245.
    View in: PubMed
    Score: 0.091
  135. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997 May; 4(3):358-61.
    View in: PubMed
    Score: 0.090
  136. Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men. J Infect Dis. 2017 05 01; 215(9):1352-1361.
    View in: PubMed
    Score: 0.090
  137. CD56bright NK IL-7Ra expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. J Leukoc Biol. 2017 07; 102(1):171-184.
    View in: PubMed
    Score: 0.089
  138. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression. J Virol. 2017 03 15; 91(6).
    View in: PubMed
    Score: 0.089
  139. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation. AIDS. 2017 02 20; 31(4):511-521.
    View in: PubMed
    Score: 0.089
  140. Association of cognitive activity and neurocognitive function in blacks and whites with HIV. AIDS. 2017 01 28; 31(3):437-441.
    View in: PubMed
    Score: 0.088
  141. Loneliness in Older Black Adults with Human Immunodeficiency Virus Is Associated with Poorer Cognition. Gerontology. 2017; 63(3):253-262.
    View in: PubMed
    Score: 0.088
  142. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS. 2017 01 14; 31(2):199-205.
    View in: PubMed
    Score: 0.088
  143. Immunological effects of antiretroviral and immune therapies for HIV. AIDS. 1997; 11 Suppl A:S149-55.
    View in: PubMed
    Score: 0.088
  144. Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. J Acquir Immune Defic Syndr. 2016 11 01; 73(3):258-262.
    View in: PubMed
    Score: 0.087
  145. Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS. 2016 08 24; 30(13):2091-7.
    View in: PubMed
    Score: 0.086
  146. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Medicine (Baltimore). 2016 Aug; 95(33):e4483.
    View in: PubMed
    Score: 0.085
  147. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis. 1996 May; 173(5):1085-91.
    View in: PubMed
    Score: 0.084
  148. Microbiome alterations in HIV infection a review. Cell Microbiol. 2016 May; 18(5):645-51.
    View in: PubMed
    Score: 0.084
  149. The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. AIDS Res Hum Retroviruses. 2016 07; 32(7):636-47.
    View in: PubMed
    Score: 0.084
  150. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. AIDS. 2016 Mar 27; 30(6):869-78.
    View in: PubMed
    Score: 0.083
  151. Systemic Immune Activation and HIV Shedding in the Female Genital Tract. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):155-62.
    View in: PubMed
    Score: 0.082
  152. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):163-71.
    View in: PubMed
    Score: 0.082
  153. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):172-80.
    View in: PubMed
    Score: 0.082
  154. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Na?ve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Jan; 12(1):e1005381.
    View in: PubMed
    Score: 0.082
  155. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis. 1995 Nov; 172(5):1221-7.
    View in: PubMed
    Score: 0.081
  156. Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study. Clin Infect Dis. 2015 Oct 01; 61(7):1179-88.
    View in: PubMed
    Score: 0.079
  157. Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):11-7.
    View in: PubMed
    Score: 0.078
  158. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 2016 Jan; 9(1):24-37.
    View in: PubMed
    Score: 0.078
  159. Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial. AIDS. 2015 Apr 24; 29(7):847-51.
    View in: PubMed
    Score: 0.078
  160. HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis. Clin Infect Dis. 2015 Aug 15; 61(4):640-50.
    View in: PubMed
    Score: 0.078
  161. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection. BMC Infect Dis. 2015 Apr 17; 15:190.
    View in: PubMed
    Score: 0.078
  162. CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy. PLoS One. 2015; 10(3):e0115019.
    View in: PubMed
    Score: 0.077
  163. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry. 1995 Mar 15; 22(1):10-5.
    View in: PubMed
    Score: 0.077
  164. Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects. J Immunol. 2014 Dec 01; 193(11):5595-603.
    View in: PubMed
    Score: 0.076
  165. Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286. J Infect Dis. 2015 Mar 01; 211(5):780-90.
    View in: PubMed
    Score: 0.075
  166. Older age is associated with peripheral blood expansion of na?ve B cells in HIV-infected subjects on antiretroviral therapy. PLoS One. 2014; 9(9):e107064.
    View in: PubMed
    Score: 0.075
  167. A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):399-406.
    View in: PubMed
    Score: 0.074
  168. Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. J Infect Dis. 2014 Nov 15; 210(10):1549-54.
    View in: PubMed
    Score: 0.073
  169. Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the US. PLoS One. 2014; 9(5):e96844.
    View in: PubMed
    Score: 0.073
  170. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One. 2014; 9(4):e92934.
    View in: PubMed
    Score: 0.073
  171. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1085-92.
    View in: PubMed
    Score: 0.072
  172. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One. 2014; 9(3):e86461.
    View in: PubMed
    Score: 0.072
  173. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One. 2014; 9(2):e85869.
    View in: PubMed
    Score: 0.072
  174. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. AIDS. 2014 Jan 28; 28(3):297-309.
    View in: PubMed
    Score: 0.072
  175. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 2014 Jul; 7(4):983-94.
    View in: PubMed
    Score: 0.071
  176. HIV infection: diagnosis and disease progression evaluation. Methods Cell Biol. 1994; 42 Pt B:437-55.
    View in: PubMed
    Score: 0.071
  177. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993 Dec; 7(12):1565-8.
    View in: PubMed
    Score: 0.071
  178. Characterization of CD4? T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr. 2013 Nov 01; 64(3):232-40.
    View in: PubMed
    Score: 0.070
  179. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. 2014 Jul; 69(7):833-42.
    View in: PubMed
    Score: 0.070
  180. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis. J Acquir Immune Defic Syndr. 2013 Oct 01; 64(2):204-10.
    View in: PubMed
    Score: 0.070
  181. Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS. 2013 Jun 01; 27(9):1516-9.
    View in: PubMed
    Score: 0.068
  182. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS. 2013 Jun 01; 27(9):1473-81.
    View in: PubMed
    Score: 0.068
  183. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis. 2013 Aug 15; 208(4):679-89.
    View in: PubMed
    Score: 0.068
  184. Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One. 2013; 8(4):e61973.
    View in: PubMed
    Score: 0.068
  185. The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 2013 Jun 06; 121(23):4635-46.
    View in: PubMed
    Score: 0.068
  186. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J Acquir Immune Defic Syndr (1988). 1993 Feb; 6(2):171-5.
    View in: PubMed
    Score: 0.067
  187. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One. 2013; 8(1):e55279.
    View in: PubMed
    Score: 0.067
  188. Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis. 2012 Dec; 225(2):408-11.
    View in: PubMed
    Score: 0.065
  189. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals. AIDS. 1992 Sep; 6(9):1047.
    View in: PubMed
    Score: 0.065
  190. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr. 2012 Aug 01; 60(4):359-68.
    View in: PubMed
    Score: 0.065
  191. MDSC: a new player in HIV immunopathogenesis. AIDS. 2012 Jul 31; 26(12):1567-9.
    View in: PubMed
    Score: 0.065
  192. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012 07 20; 12(8):607-14.
    View in: PubMed
    Score: 0.064
  193. Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection. J Infect Dis. 2012 Sep 15; 206(6):969-73.
    View in: PubMed
    Score: 0.064
  194. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18.
    View in: PubMed
    Score: 0.064
  195. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012 Aug 15; 206(4):534-42.
    View in: PubMed
    Score: 0.064
  196. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. J Infect Dis. 2012 Sep 01; 206(5):780-9.
    View in: PubMed
    Score: 0.064
  197. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012 Apr 24; 26(7):843-53.
    View in: PubMed
    Score: 0.063
  198. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012 Jun 15; 205(12):1788-96.
    View in: PubMed
    Score: 0.063
  199. CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. J Infect Dis. 2012 Jun; 205(11):1730-8.
    View in: PubMed
    Score: 0.063
  200. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One. 2012; 7(1):e30306.
    View in: PubMed
    Score: 0.062
  201. HIV infection and aging of the innate immune system. Sex Health. 2011 Dec; 8(4):453-64.
    View in: PubMed
    Score: 0.062
  202. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS. 2011 Sep 24; 25(15):1823-32.
    View in: PubMed
    Score: 0.061
  203. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS. 2011 Jun 01; 25(9):1207-17.
    View in: PubMed
    Score: 0.060
  204. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis. 2011 Jul; 217(1):207-13.
    View in: PubMed
    Score: 0.059
  205. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS. 1991 Mar; 5(3):289-93.
    View in: PubMed
    Score: 0.059
  206. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3.
    View in: PubMed
    Score: 0.058
  207. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011 Jan 31; 6(1):e15924.
    View in: PubMed
    Score: 0.058
  208. HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy. AIDS. 2011 Jan 14; 25(2):159-64.
    View in: PubMed
    Score: 0.058
  209. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis. 2011 Feb 15; 203(4):452-63.
    View in: PubMed
    Score: 0.058
  210. Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis. 1990 Dec; 162(6):1239-44.
    View in: PubMed
    Score: 0.058
  211. Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl Environ Microbiol. 2011 Jan; 77(1):378-81.
    View in: PubMed
    Score: 0.057
  212. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection. J Infect Dis. 1990 Nov; 162(5):1018-24.
    View in: PubMed
    Score: 0.057
  213. Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis. 2010 Aug 15; 202(3):386-91.
    View in: PubMed
    Score: 0.056
  214. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS. 2010 Jul 17; 24(11):1657-65.
    View in: PubMed
    Score: 0.056
  215. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. Clin Vaccine Immunol. 2010 Sep; 17(9):1452-9.
    View in: PubMed
    Score: 0.056
  216. Application of flow cytometry to the study of HIV infection. AIDS. 1990 Jun; 4(6):479-97.
    View in: PubMed
    Score: 0.056
  217. Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals. Clin Immunol Immunopathol. 1990 Feb; 54(2):184-91.
    View in: PubMed
    Score: 0.054
  218. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clin Immunol. 2010 Apr; 135(1):12-25.
    View in: PubMed
    Score: 0.054
  219. Flow cytometric monitoring of human immunodeficiency virus-infected patients. Simultaneous enumeration of five lymphocyte subsets. Am J Clin Pathol. 1989 Dec; 92(6):721-8.
    View in: PubMed
    Score: 0.054
  220. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009 Jun 18; 113(25):6304-14.
    View in: PubMed
    Score: 0.051
  221. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009 Apr 15; 199(8):1177-85.
    View in: PubMed
    Score: 0.051
  222. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-10.
    View in: PubMed
    Score: 0.051
  223. Effect of mucosal fluid from women with bacterial vaginosis on HIV trans-infection mediated by dendritic cells. Virology. 2009 Mar 01; 385(1):22-7.
    View in: PubMed
    Score: 0.050
  224. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol. 2009 Jun; 4(2):163-74.
    View in: PubMed
    Score: 0.050
  225. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Dec 01; 49(4):348-57.
    View in: PubMed
    Score: 0.050
  226. CD4 immunophenotyping in HIV infection. Nat Rev Microbiol. 2008 Nov; 6(11 Suppl):S7-15.
    View in: PubMed
    Score: 0.050
  227. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis. 2008 Oct 15; 198(8):1131-40.
    View in: PubMed
    Score: 0.050
  228. In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. Clin Vaccine Immunol. 2008 Sep; 15(9):1398-409.
    View in: PubMed
    Score: 0.049
  229. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS. 2008 Jun 19; 22(10):1131-5.
    View in: PubMed
    Score: 0.049
  230. Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses. 2008 Feb; 24(2):163-8.
    View in: PubMed
    Score: 0.047
  231. Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. J Infect Dis. 2008 Jan 15; 197(2):319-27.
    View in: PubMed
    Score: 0.047
  232. Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS. 2007 Nov 12; 21(17):2363-5.
    View in: PubMed
    Score: 0.047
  233. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007 Dec 05; 369(1):55-68.
    View in: PubMed
    Score: 0.046
  234. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr. 2007 May 01; 45(1):9-19.
    View in: PubMed
    Score: 0.045
  235. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605.
    View in: PubMed
    Score: 0.045
  236. HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):269-77.
    View in: PubMed
    Score: 0.044
  237. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS. 2007 Jan 30; 21(3):293-305.
    View in: PubMed
    Score: 0.044
  238. Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. J Infect Dis. 2007 Mar 01; 195(5):734-8.
    View in: PubMed
    Score: 0.044
  239. A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115. Antivir Ther. 2007; 12(4):531-41.
    View in: PubMed
    Score: 0.044
  240. Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics. Nature. 2006 Nov 23; 444 Suppl 1:19-28.
    View in: PubMed
    Score: 0.044
  241. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 Dec; 12(12):1365-71.
    View in: PubMed
    Score: 0.044
  242. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol. 2006 Oct; 80(20):10162-72.
    View in: PubMed
    Score: 0.043
  243. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol. 2006 Nov; 48(2):267-73.
    View in: PubMed
    Score: 0.043
  244. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis. 2006 Oct 15; 194(8):1098-107.
    View in: PubMed
    Score: 0.043
  245. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis. 2006 Jul 01; 194(1):29-37.
    View in: PubMed
    Score: 0.042
  246. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006 Aug; 120(2):138-46.
    View in: PubMed
    Score: 0.042
  247. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis. 2006 May 01; 193(9):1202-10.
    View in: PubMed
    Score: 0.042
  248. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis. 2005 Nov 01; 192(9):1577-87.
    View in: PubMed
    Score: 0.040
  249. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005 Aug 13-19; 366(9485):549-55.
    View in: PubMed
    Score: 0.040
  250. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004 Dec 01; 190(11):1970-8.
    View in: PubMed
    Score: 0.038
  251. Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS. 2004 Sep 24; 18(14):1953-6.
    View in: PubMed
    Score: 0.037
  252. HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis. 2004 Aug 01; 190(3):619-23.
    View in: PubMed
    Score: 0.037
  253. Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr. 2004 Jun 01; 36(2):659-70.
    View in: PubMed
    Score: 0.037
  254. Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS. 2004 Mar 05; 18(4):605-13.
    View in: PubMed
    Score: 0.036
  255. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science. 2004 Jan 16; 303(5656):316.
    View in: PubMed
    Score: 0.036
  256. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
    View in: PubMed
    Score: 0.036
  257. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection. J Infect Dis. 2003 Dec 15; 188(12):1804-14.
    View in: PubMed
    Score: 0.035
  258. MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study. J Acquir Immune Defic Syndr. 2003 Nov 01; 34(3):295-8.
    View in: PubMed
    Score: 0.035
  259. Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 Aug 15; 37(4):551-8.
    View in: PubMed
    Score: 0.035
  260. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood. 2003 Sep 15; 102(6):2156-64.
    View in: PubMed
    Score: 0.034
  261. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr. 2003 Jun 01; 33(2):175-83.
    View in: PubMed
    Score: 0.034
  262. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33.
    View in: PubMed
    Score: 0.034
  263. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
    View in: PubMed
    Score: 0.033
  264. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5.
    View in: PubMed
    Score: 0.033
  265. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology. 2003 Jan; 108(1):3-9.
    View in: PubMed
    Score: 0.033
  266. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol. 2002 Sep; 161(3):867-73.
    View in: PubMed
    Score: 0.032
  267. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5.
    View in: PubMed
    Score: 0.032
  268. A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS. 2002 May 24; 16(8):1147-54.
    View in: PubMed
    Score: 0.032
  269. Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens. J Acquir Immune Defic Syndr. 2002 Apr 15; 29(5):544-5.
    View in: PubMed
    Score: 0.032
  270. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med. 2002 Jan; 8(1):47-53.
    View in: PubMed
    Score: 0.031
  271. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2001 Sep 01; 17(13):1231-40.
    View in: PubMed
    Score: 0.030
  272. A potential role for interleukin-7 in T-cell homeostasis. Blood. 2001 May 15; 97(10):2983-90.
    View in: PubMed
    Score: 0.030
  273. Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol. 2000 Dec; 157(6):1811-8.
    View in: PubMed
    Score: 0.029
  274. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS. 2000 Dec 01; 14(17):2635-42.
    View in: PubMed
    Score: 0.029
  275. T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy. AIDS Res Hum Retroviruses. 2000 Nov 20; 16(17):1887-93.
    View in: PubMed
    Score: 0.029
  276. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 2000 Nov 01; 96(9):2951-64.
    View in: PubMed
    Score: 0.029
  277. Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000 Oct 01; 25(2):150-6.
    View in: PubMed
    Score: 0.028
  278. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS. 2000 Sep 29; 14(14):2101-7.
    View in: PubMed
    Score: 0.028
  279. Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol. 2000 Sep; 7(5):759-63.
    View in: PubMed
    Score: 0.028
  280. Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation. Clin Diagn Lab Immunol. 2000 Jul; 7(4):540-8.
    View in: PubMed
    Score: 0.028
  281. Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS. 2020 05 01; 34(6):849-857.
    View in: PubMed
    Score: 0.028
  282. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immunol Methods. 2000 Apr 03; 237(1-2):187-97.
    View in: PubMed
    Score: 0.027
  283. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team. J Infect Dis. 2000 Feb; 181(2):491-7.
    View in: PubMed
    Score: 0.027
  284. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team. Blood. 2000 Jan 01; 95(1):48-55.
    View in: PubMed
    Score: 0.027
  285. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis. 2000 Jan; 181(1):141-7.
    View in: PubMed
    Score: 0.027
  286. Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis. 2000 Jan; 181(1):148-57.
    View in: PubMed
    Score: 0.027
  287. Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons. AIDS Res Hum Retroviruses. 1999 Dec 10; 15(18):1713-5.
    View in: PubMed
    Score: 0.027
  288. Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment. J Neurovirol. 2020 02; 26(1):107-113.
    View in: PubMed
    Score: 0.026
  289. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.
    View in: PubMed
    Score: 0.026
  290. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol. 1999 Aug 01; 163(3):1666-73.
    View in: PubMed
    Score: 0.026
  291. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS. 1999 Jul 30; 13(11):1295-303.
    View in: PubMed
    Score: 0.026
  292. HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication. AIDS. 1999 Jul 09; 13(10):1177-85.
    View in: PubMed
    Score: 0.026
  293. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells. Clin Immunol. 1999 Jul; 92(1):14-24.
    View in: PubMed
    Score: 0.026
  294. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin Immunol. 1999 Jun; 91(3):254-62.
    View in: PubMed
    Score: 0.026
  295. Cytokine modulation of HIV-1 chemokine receptor expression. Nat Med. 1999 Jun; 5(6):592-3.
    View in: PubMed
    Score: 0.026
  296. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers. Infect Control Hosp Epidemiol. 1999 Jun; 20(6):428-30.
    View in: PubMed
    Score: 0.026
  297. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25.
    View in: PubMed
    Score: 0.026
  298. Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection. AIDS. 2019 05 01; 33(6):1043-1052.
    View in: PubMed
    Score: 0.026
  299. Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 1999 May; 6(3):427-8.
    View in: PubMed
    Score: 0.026
  300. Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures. JAMA. 1999 Mar 24-31; 281(12):1085-6.
    View in: PubMed
    Score: 0.025
  301. Vitamin D does not modulate immune-mediated bone loss during ART initiation. Antivir Ther. 2019; 24(5):355-362.
    View in: PubMed
    Score: 0.025
  302. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol. 1998 Nov; 72(11):9054-60.
    View in: PubMed
    Score: 0.025
  303. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol. 1998 Aug; 153(2):481-90.
    View in: PubMed
    Score: 0.024
  304. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest. 1998 Jul 01; 102(1):79-87.
    View in: PubMed
    Score: 0.024
  305. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis. 1998 Jul; 178(1):70-9.
    View in: PubMed
    Score: 0.024
  306. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA. 1998 Jul 01; 280(1):72-7.
    View in: PubMed
    Score: 0.024
  307. Rationale for immune-based therapies for HIV-1 infection. J Lab Clin Med. 1998 Mar; 131(3):197-206.
    View in: PubMed
    Score: 0.024
  308. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol. 1998 Feb; 28(2):646-56.
    View in: PubMed
    Score: 0.024
  309. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction. J Virol. 2017 12 01; 91(23).
    View in: PubMed
    Score: 0.023
  310. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8.
    View in: PubMed
    Score: 0.023
  311. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS. 1997 Jul; 11(8):1013-21.
    View in: PubMed
    Score: 0.023
  312. Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol. 1997 Jun; 89(6):967-74.
    View in: PubMed
    Score: 0.023
  313. Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood. Am J Med. 1997 May 19; 102(5B):21-4.
    View in: PubMed
    Score: 0.023
  314. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study. J Infect Dis. 1997 Mar; 175(3):567-75.
    View in: PubMed
    Score: 0.022
  315. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 1997 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.022
  316. Contribution of prostaglandin E2 to the interleukin-12 defect in HIV-infected patients. AIDS. 1996 Aug; 10(9):1043-5.
    View in: PubMed
    Score: 0.021
  317. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis. 1996 Jul; 174(1):46-53.
    View in: PubMed
    Score: 0.021
  318. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS. 1996 Jun; 10(6):603-11.
    View in: PubMed
    Score: 0.021
  319. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015 Jul; 22(7):702-9.
    View in: PubMed
    Score: 0.020
  320. T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN. PLoS One. 2015; 10(6):e0130146.
    View in: PubMed
    Score: 0.020
  321. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. Clin Immunol Immunopathol. 1995 Apr; 75(1):20-5.
    View in: PubMed
    Score: 0.019
  322. Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. J Clin Invest. 2014 Jun; 124(6):2802-6.
    View in: PubMed
    Score: 0.018
  323. A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol. 1994 Apr; 71(1):8-13.
    View in: PubMed
    Score: 0.018
  324. Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study. PLoS One. 2014; 9(1):e85675.
    View in: PubMed
    Score: 0.018
  325. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 1994 Jan 05; 271(1):42-6.
    View in: PubMed
    Score: 0.018
  326. In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS. 1993 Jan; 7(1):37-41.
    View in: PubMed
    Score: 0.017
  327. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons. Immunology. 1992 Jan; 75(1):59-65.
    View in: PubMed
    Score: 0.016
  328. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis. Immunology. 1991 Aug; 73(4):377-82.
    View in: PubMed
    Score: 0.015
  329. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol. 2011 Aug; 18(8):1229-42.
    View in: PubMed
    Score: 0.015
  330. Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J Immunol. 1991 Apr 01; 146(7):2207-13.
    View in: PubMed
    Score: 0.015
  331. Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):635-43.
    View in: PubMed
    Score: 0.014
  332. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis. 2010 Mar 15; 201(6):823-34.
    View in: PubMed
    Score: 0.014
  333. Activation of complement on the surface of cells infected by human immunodeficiency virus. J Immunol. 1990 Feb 15; 144(4):1490-6.
    View in: PubMed
    Score: 0.014
  334. Absolute number versus percentage of T-helper lymphocytes in human immunodeficiency virus infection. J Infect Dis. 1990 Feb; 161(2):356-7.
    View in: PubMed
    Score: 0.014
  335. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci U S A. 2003 Oct 28; 100(22):12972-7.
    View in: PubMed
    Score: 0.009
  336. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest. 2001 Feb; 107(3):287-94.
    View in: PubMed
    Score: 0.007
  337. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest. 1995 Aug; 96(2):867-76.
    View in: PubMed
    Score: 0.005
  338. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology. 1993 Aug; 195(2):475-80.
    View in: PubMed
    Score: 0.004
  339. Complement activation by human monoclonal antibodies to human immunodeficiency virus. J Virol. 1993 Jan; 67(1):53-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.